Cargando…
254 Patient perception of the impact of elexacaftor/tezacaftor/ivacaftor and the COVID-19 pandemic on physical and mental health
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Cystic Fibrosis Society.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527869/ http://dx.doi.org/10.1016/S1569-1993(22)00944-4 |
_version_ | 1784801168999841792 |
---|---|
author | Sakon, C. Vogt, H. Brown, C. Tillman, E. |
author_facet | Sakon, C. Vogt, H. Brown, C. Tillman, E. |
author_sort | Sakon, C. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9527869 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | European Cystic Fibrosis Society. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95278692022-10-03 254 Patient perception of the impact of elexacaftor/tezacaftor/ivacaftor and the COVID-19 pandemic on physical and mental health Sakon, C. Vogt, H. Brown, C. Tillman, E. J Cyst Fibros Posters European Cystic Fibrosis Society. 2022-10 2022-10-03 /pmc/articles/PMC9527869/ http://dx.doi.org/10.1016/S1569-1993(22)00944-4 Text en Copyright © 2022 European Cystic Fibrosis Society. All rights reserved. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Posters Sakon, C. Vogt, H. Brown, C. Tillman, E. 254 Patient perception of the impact of elexacaftor/tezacaftor/ivacaftor and the COVID-19 pandemic on physical and mental health |
title | 254 Patient perception of the impact of elexacaftor/tezacaftor/ivacaftor and the COVID-19 pandemic on physical and mental health |
title_full | 254 Patient perception of the impact of elexacaftor/tezacaftor/ivacaftor and the COVID-19 pandemic on physical and mental health |
title_fullStr | 254 Patient perception of the impact of elexacaftor/tezacaftor/ivacaftor and the COVID-19 pandemic on physical and mental health |
title_full_unstemmed | 254 Patient perception of the impact of elexacaftor/tezacaftor/ivacaftor and the COVID-19 pandemic on physical and mental health |
title_short | 254 Patient perception of the impact of elexacaftor/tezacaftor/ivacaftor and the COVID-19 pandemic on physical and mental health |
title_sort | 254 patient perception of the impact of elexacaftor/tezacaftor/ivacaftor and the covid-19 pandemic on physical and mental health |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527869/ http://dx.doi.org/10.1016/S1569-1993(22)00944-4 |
work_keys_str_mv | AT sakonc 254patientperceptionoftheimpactofelexacaftortezacaftorivacaftorandthecovid19pandemiconphysicalandmentalhealth AT vogth 254patientperceptionoftheimpactofelexacaftortezacaftorivacaftorandthecovid19pandemiconphysicalandmentalhealth AT brownc 254patientperceptionoftheimpactofelexacaftortezacaftorivacaftorandthecovid19pandemiconphysicalandmentalhealth AT tillmane 254patientperceptionoftheimpactofelexacaftortezacaftorivacaftorandthecovid19pandemiconphysicalandmentalhealth |